News

Manhattan Bridge Capital Unveils Stock Repurchase Plan for Growth

Manhattan Bridge Capital Unveils Stock Repurchase Plan for Growth

Manhattan Bridge Capital Plans to Buy Back Shares

Manhattan Bridge Capital, Inc. (NASDAQ: LOAN) has announced a strategic plan to repurchase up to 100,000 of its common shares. This decision comes as part of the company's efforts to enhance value for its shareholders during a period of stock price fluctuations.

Understanding the Buyback Initiative

The company's Board of Directors has approved this purchase plan, allowing the repurchase of shares either in market or off-market transactions over the next twelve months. The specifics regarding the timing and volume of shares purchased will be determined solely by the management of Manhattan Bridge Capital.

CEO Comments on Market Conditions

Assaf Ran, the Chairman of the Board and Chief Executive Officer, expressed belief that the current decrease in stock price presents a unique opportunity for the company. He mentioned, "Our stock has been affected dramatically, and I see this as a chance for us to buy back shares. With our incredibly low leverage and strong management commitment, we feel confident in this decision and what it conveys about our future prospects."

About Manhattan Bridge Capital, Inc.

Manhattan Bridge Capital operates in a specialized niche within the real estate finance sector. Offering short-term secured loans, often referred to as "hard money" loans, the company serves real estate investors seeking funds for property acquisition and improvements in the New York metropolitan area, which extends to regions in New Jersey and Connecticut, as well as Florida. For more information, you can visit the company’s website.

Repurchase Program Implications

The proposed share repurchase might have several implications for the company. Primarily, it could signal to the market that the company's shares are undervalued, potentially boosting investor confidence. Furthermore, reducing the number of outstanding shares can enhance earnings per share, making the stock more attractive to investors.

Market Strategy and Future Plans

Long-term viability and growth strategies are essential for Manhattan Bridge Capital. By engaging in share repurchase activities, the company aims to reinforce its position in a competitive marketplace. By maintaining a strong balance sheet and focusing on areas where it can leverage its strengths, Manhattan Bridge Capital intends to pursue ongoing business expansion opportunities.

Commitment to Stakeholders

This share repurchase initiative illustrates the company's commitment to its stakeholders. By investing in its own equity, Manhattan Bridge Capital not only seeks to stabilize its stock price but also expresses a pledge to the community and to investors that the company values their continued support and trust.

Frequently Asked Questions

What prompted Manhattan Bridge Capital to initiate a buyback plan?

The dramatic decline in their stock price combined with a strong management commitment motivated the buyback plan.

How will the repurchase impact current shareholders?

The buyback can enhance earnings per share and potentially increase stock value, thereby benefiting shareholders.

What type of loans does Manhattan Bridge Capital provide?

They offer short-term, secured "hard money" loans primarily to real estate investors for property funding and improvements.

Where does Manhattan Bridge Capital operate?

The company primarily operates in the New York metropolitan area but also serves regions in New Jersey, Connecticut, and Florida.

Who makes decisions about the share repurchase timing?

The timing and manner of share purchases are at the discretion of the company’s management.

About The Author

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.

Top 10 Most Recent News Articles

Cardinal Health Surges with Increased EPS Outlook

Updated Category News Views 111

Cardinal Health's Towering Numbers and Raised Outlook Holy moly, Cardinal Health is strutting out of the gate like they mean business. Their first quarter for fiscal year 2027 showed revenue hitting a hefty $67.5 billion—up 5% from last year. If you're holding NYSE:CAH, you might be grinning ear to ear right now. Cardinal didn’t just squeeze out more revenue; they saw...

Continue Reading
Verismo's SynKIR™-310 Shows Promise in Phase 1 Trials

Updated Category News Views 74

KIR-CAR: A Fresh Take on Cancer Treatment So, Verismo Therapeutics is at it again with their KIR-CAR platform. They're set to present interim data at this year's ASH Annual Meeting. To all those following B-cell non-Hodgkin Lymphoma (B-NHL) treatments, pay attention. SynKIR™-310, a CD19-targeted therapy, is showing some real promise. The science behind this is like...

Continue Reading
Mondego Bio Charges Ahead with Cancer Therapy Trials

Updated Category News Views 78

Cracking Cancer's Code: Mondego's Bold Move Big news from Portugal today—a quiet town called Cantanhede is now the epicenter of a potential game-changer in cancer therapy. Mondego Bio, with its small-molecule innovator MB?388, is diving headfirst into a Phase 1 clinical study. If you're scratching your head about the significance, let me spell it out: this is an attempt...

Continue Reading
Chris Auffenberg Delivers Ford Blue Advantage Gains

Updated Category News Views 18

Can't Ignore Ford's New Strategy in Pre-Owned Cars The auto industry may feel like a runaway train sometimes, and keeping up with the latest turns can be a headache. But here's something catching my eye: Chris Auffenberg Ford's new move with the Ford Blue Advantage certified pre-owned vehicles. It's not just any run-of-the-mill used car deal—this one's got some beef...

Continue Reading
Reviving Carbide Tools: Resharpening for Cost Control

Updated Category News Views 52

Trading Rust: Resharpening Carbide Cutting Tools Alright, picture this: you've got a toolbox full of worn carbide tools, each looking like they've seen better days. You might toss 'em out and grab some new ones, right? But hold on! Carl Ciesla, a cutting tool vet from Sanborn, NY, is talking all about how resharpening could be your ticket to saving a heap of cash and...

Continue Reading
Norwegian Cruise Line's Black Friday Big Splash

Updated Category News Views 65

Jump Aboard NCL's Black Friday Bargain Ship Grab your life jackets, folks! Norwegian Cruise Line (NCL) is sailing with an irresistible Black Friday offer: 50% off all cruises, complete with their much-lauded Free at Sea package. Yeah, if you've been fence-sitting about taking the plunge into the cruise lifestyle, now might just be the time to buckle up your life vests. A...

Continue Reading
Bioactive Research: Converting Science into Guidance

Updated Category News Views 0

Unlocking the Science of Dietary Bioactives Amidst a world swimming in kale smoothies and exotic teas, ILSI U.S. & Canada gathered the sharpest minds to discuss dietary bioactives, an area once shrugged off but now coming into its own. On October 28, 2026, over 250 folks from government, academia, and industry tuned in, looking to understand how these compounds, found in...

Continue Reading
Aker Solutions Lands Big Role in Qatar Oil Upgrade

Updated Category News Views 88

Qatari Venture Beckons Aker Solutions Well, it's not every day you hear about a decades-old oil field getting a facelift, and yet here we are. Aker Solutions has received a nod of approval with a letter of award from PTSC Mechanical and Construction Limited Company (PTSC M&C). This gig is all about the Maydan Mahzam oil field way off the Qatari coast—a legacy site...

Continue Reading
Utility Returns: Short-Term Savings, Long-Term Costs

Updated Category News Views 64

Crunching the Numbers on Utility Returns There's a buzz in the utility sector, and it's not just the hum of power lines—it’s all about return on equity (ROE). Concentric Energy Advisors just dropped some insights that could have us rethinking how these returns play into customer bills and utilities' financing capabilities. What's the Deal with ROE? Think of ROE like a...

Continue Reading
Qfin Faces Stock Lawsuit: Know Your Investor Rights

Updated Category News Views 82

Qfin in the Legal Hot Seat When you hear about a company's legal wranglings, especially one like Qfin Holdings, Inc., you've got to sit up and take notice. We're not talking about a quick scuffle here; this is a full-blown class action lawsuit with its talons sunk deep into allegations of securities law violations. They're squared off against DJS Law Group, an outfit that...

Continue Reading

Top 5 Most Recently Viewed Articles

M-DAQ Expands Footprint: Eyes Vietnam's Booming Economy

Updated Category News Views 51

Strategic Moves in the ASEAN Financial Arena Now, this one's got some bite to it. M-DAQ Global's foray into Vietnam isn't just another step on the fintech ladder - it's a bold expansion play into one of ASEAN's fastest up-and-comers. Forget the usual corporate fluff; what we're seeing here is a calculated strike to grab a piece of a pie that's only getting bigger. Why...

Continue Reading
IDEAYA Biosciences, Inc. Reports Strong Progress in 2024

Updated Category News Views 194

IDEAYA Biosciences, Inc. Achieves Significant Milestones in Financial Reporting IDEAYA Biosciences, Inc. (Nasdaq: IDYA), a pioneering precision medicine oncology company, recently shared its financial results for the fourth quarter and the full year of 2024. The company is dedicated to the discovery and development of targeted therapeutics, making noteworthy strides...

Continue Reading
5N Plus Inc. Enhances Supply Partnership with First Solar

Updated Category News Views 256

Introduction to the New Supply Agreement 5N Plus Inc. (TSX: VNP), a global leader in specialty semiconductors and performance materials, recently announced a major expansion of its supply agreement with First Solar, Inc. (NASDAQ: FSLR). This partnership is vital in supplying increased volumes of critical materials essential for the production of photovoltaic solar...

Continue Reading
Energy Services of America Shines at Upcoming Investor Conference

Updated Category News Views 162

Highlighting Energy Services of America's Upcoming Investor Conference Energy Services of America (NASDAQ: ESOA) is preparing to make a significant impact at an upcoming investor conference. The event will feature presentations by the company's top executives, providing insights into the organization’s future strategies and objectives. Key Presenters at the Conference...

Continue Reading
Ophthalmic Drugs Market Expected to Hit $67.83 Billion by 2033

Updated Category News Views 51

Overview of the Ophthalmic Drugs Market The ophthalmic drugs market is experiencing impressive growth, largely due to the increasing prevalence of eye diseases and innovative advancements in drug development. In 2023, the market was valued at USD 37.17 billion and is expected to grow at a remarkable CAGR of 6.2% from 2024 to 2033, surpassing USD 67.83 billion. Recent...

Continue Reading